Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Targeting complement activation in COVID-19

Hrishikesh S. Kulkarni, John P. Atkinson

Blood (2020) 136 (18): 2000–2001.

https://doi.org/10.1182/blood.2020008925

Published: 2020

Journal Articles

CD46 Is Amplified in High-Risk Myeloma with Gain of Chromosome 1q and Selectively Targeted By a Novel Anti-CD46 Antibody-Drug Conjugate

Daniel W. Sherbenou, MD PhD, Blake T. Aftab, PhD, Yang Su, PhD, Christopher R. Behrens, PhD, Arun P. Wiita, MD PhD, Aaron C. Logan, MD PhD, Diego Acosta-Alvear, PhD, Byron C. Hann, MD PhD, Peter Walter, PhD, Xiaobo Wu, MD, John P. Atkinson, MD, Jeffrey L. Wolf, MD, Thomas G. Martin, III, MD, Bin Liu, PhD

Blood (2016) 128 (22): 384.

https://doi.org/10.1182/blood.V128.22.384.384

Published: 2016

Journal Articles

Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome

Elizabeth C. Schramm, Lubka T. Roumenina, Tania Rybkine, Sophie Chauvet, Paula Vieira-Martins, Christophe Hue, Tara Maga, Elisabetta Valoti, Valerie Wilson, Sakari Jokiranta, Richard J. H. Smith, Marina Noris, Tim Goodship, John P. Atkinson, Veronique Fremeaux-Bacchi

Blood (2015) 125 (15): 2359–2369.

https://doi.org/10.1182/blood-2014-10-609073

Published: 2015

Includes: Supplemental data

Journal Articles

Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis

Sergei Zaitsev, M. Anna Kowalska, Michael Neyman, Ronald Carnemolla, Samira Tliba, Bi-Sen Ding, Aaron Stonestrom, Dirk Spitzer, John P. Atkinson, Mortimer Poncz, Douglas B. Cines, Charles T. Esmon, Vladimir R. Muzykantov

Blood (2012) 119 (20): 4779–4785.

https://doi.org/10.1182/blood-2011-12-398149

Published: 2012

Includes: Multimedia, Supplemental data

Journal Articles

A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function

Lubka T. Roumenina, Marie Frimat, Elizabeth C. Miller, Francois Provot, Marie-Agnes Dragon-Durey, Pauline Bordereau, Sylvain Bigot, Christophe Hue, Simon C. Satchell, Peter W. Mathieson, Christiane Mousson, Christian Noel, Catherine Sautes-Fridman, Lise Halbwachs-Mecarelli, John P. Atkinson, Arnaud Lionet, Veronique Fremeaux-Bacchi

Blood (2012) 119 (18): 4182–4191.

https://doi.org/10.1182/blood-2011-10-383281

Published: 2012

Journal Articles

Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes

Wai-Hong Tham, Christoph Q. Schmidt, Richard E. Hauhart, Mara Guariento, Patience B. Tetteh-Quarcoo, Sash Lopaticki, John P. Atkinson, Paul N. Barlow, Alan F. Cowman

Blood (2011) 118 (7): 1923–1933.

https://doi.org/10.1182/blood-2011-03-341305

Published: 2011

Includes: Supplemental data

Journal Articles

Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation

Sergei Zaitsev, Dirk Spitzer, Juan-Carlos Murciano, Bi-Sen Ding, Samira Tliba, M. Anna Kowalska, Oscar A. Marcos-Contreras, Alice Kuo, Victoria Stepanova, John P. Atkinson, Mortimer Poncz, Douglas B. Cines, Vladimir R. Muzykantov

Blood (2010) 115 (25): 5241–5248.

https://doi.org/10.1182/blood-2010-01-261610

Published: 2010

Includes: Supplemental data

Journal Articles

Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome

Blood (2008) 112 (13): 4948–4952.

https://doi.org/10.1182/blood-2008-01-133702

Published: 2008

Includes: Supplemental data

Journal Articles

Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome

Celia J. Fang, Veronique Fremeaux-Bacchi, M. Kathryn Liszewski, Gaia Pianetti, Marina Noris, Timothy H. J. Goodship, John P. Atkinson

Blood (2008) 111 (2): 624–632.

https://doi.org/10.1182/blood-2007-04-084533

Published: 2008

Includes: Supplemental data

Journal Articles

Genetics of HUS: the impact of MCP, CFH , and IF mutations on clinical presentation, response to treatment, and outcome

Jessica Caprioli, Marina Noris, Simona Brioschi, Gaia Pianetti, Federica Castelletti, Paola Bettinaglio, Caterina Mele, Elena Bresin, Linda Cassis, Sara Gamba, Francesca Porrati, Sara Bucchioni, Giuseppe Monteferrante, Celia J. Fang, M. K. Liszewski, David Kavanagh, John P. Atkinson, Giuseppe Remuzzi, for the International Registry of Recurrent and Familial HUS/TTP

Blood (2006) 108 (4): 1267–1279.

https://doi.org/10.1182/blood-2005-10-007252

Published: 2006

Journal Articles

Complement-induced regulatory T cells suppress T-cell responses but allow for dendritic-cell maturation

Winfried Barchet, Jeffrey D. Price, Marina Cella, Marco Colonna, Sandra K. MacMillan, J. Perren Cobb, Paul A. Thompson, Kenneth M. Murphy, John P. Atkinson, Claudia Kemper

Blood (2006) 107 (4): 1497–1504.

https://doi.org/10.1182/blood-2005-07-2951

Published: 2006

Includes: Supplemental data

Journal Articles

Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells

William J. Grossman, James W. Verbsky, Benjamin L. Tollefsen, Claudia Kemper, John P. Atkinson, Timothy J. Ley

Blood (2004) 104 (9): 2840–2848.

https://doi.org/10.1182/blood-2004-03-0859

Published: 2004

Journal Articles

Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1

Joann M. Moulds, Peter A. Zimmerman, Ogobara K. Doumbo, Lalla Kassambara, Issaka Sagara, Dapa A. Diallo, John P. Atkinson, Malgorzata Krych-Goldberg, Richard E. Hauhart, Dennis E. Hourcade, David T. McNamara, Daniel J. Birmingham, J. Alexandra Rowe, John J. Moulds, Louis H. Miller

Blood (2001) 97 (9): 2879–2885.

https://doi.org/10.1182/blood.V97.9.2879

Published: 2001

Journal Articles

Complement-independent Clearance of IgG-sensitized Erythrocytes: Inhibition by Cortisone

John P. Atkinson, Dr., Michael M. Frank

Blood (1974) 44 (5): 629–637.

https://doi.org/10.1182/blood.V44.5.629.629

Published: 1974

NARROW

Targeting complement activation in COVID-19

CD46 Is Amplified in High-Risk Myeloma with Gain of Chromosome 1q and Selectively Targeted By a Novel Anti-CD46 Antibody-Drug Conjugate

Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome

Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis

A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function

Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes

Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation

Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome

Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome

Genetics of HUS: the impact of MCP, CFH , and IF mutations on clinical presentation, response to treatment, and outcome

Complement-induced regulatory T cells suppress T-cell responses but allow for dendritic-cell maturation

Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells

Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1

Complement-independent Clearance of IgG-sensitized Erythrocytes: Inhibition by Cortisone

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only